Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Propagermanium
Drug ID BADD_D01858
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01626
MeSH ID C066750
PubChem ID 83030
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 1Q2P9TO9Q7
Synonyms propagermanium | bis(carboxyethyl)germanium sesquioxide | DCEFSQD | carboxyethylgermanium sesquioxide | dicarboxyethenylgermanium sesquioxide | repagermanium | proxigermanium | dihydrogen bis(2-carboxylatoethyl)trioxodigermanate(2-) | bis(2-carboxyethyl)germanium sesquioxide | beta carboxyethylgermanium sesquioxide | 3,3'-(1,3-dioxo-1,3-digermoxanediyl)dipropionic acid | Ge 132 | Germanium-132 | Ge-132 | Arlamol Gel | 3-oxygermylpropionic acid polymer | SK 818 | SK-818
Chemical Information
Molecular Formula C6H10Ge2O7
CAS Registry Number 12758-40-6
SMILES C(C[Ge](=O)O[Ge](=O)CCC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acute respiratory distress syndrome24.03.02.034; 10.02.01.067; 22.01.03.001--
Adenocarcinoma16.16.01.004--Not Available
Agitation17.02.05.012; 19.06.02.001--
Alanine aminotransferase increased13.03.04.005--
Anaemia01.03.02.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001--Not Available
Anuria20.01.03.002--Not Available
Aphasia19.21.01.001; 17.02.03.001--
Aplastic anaemia01.03.03.002--Not Available
Apnoea22.02.01.001--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Aspartate aminotransferase increased13.03.04.011--
Asterixis17.01.06.001; 09.01.03.004--Not Available
Asthenia08.01.01.001--Not Available
Azotaemia20.01.01.001--Not Available
B-cell lymphoma01.15.01.001; 16.28.01.001--Not Available
Blindness06.02.10.003; 17.17.01.003--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Brain herniation17.07.02.009; 12.01.10.001--Not Available
Breast cancer21.05.01.003; 16.10.01.001--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.001--
Cardiovascular disorder24.03.02.009; 02.11.01.010--Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages